GoldenGolden
Advanced Search
Paige (company)

Paige (company)

Paige is a company founded by Michael Moynahan.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Conor Hale
May 25, 2021
FierceBiotech
To help build out its own portfolio of artificial-intelligence-driven pathology tests, Quest Diagnostics has enlisted the help of Paige to develop a suite of products aimed at individual clinical oncologists as well as larger biopharma companies and their R&D efforts.
May 25, 2021
BioSpace
Quest Diagnostics and Paige Form Collaboration to Advance AI-generated Pathology Insights to Improve Cancer Diagnosis and Care - read this article along with other careers information, tips and advice on BioSpace
Inform Diagnostics
May 12, 2021
www.prnewswire.com:443
/PRNewswire/ -- Inform Diagnostics, a leading U.S. anatomic pathology provider, and Paige, a global leader in AI-based cancer diagnostic software for digital...
April 22, 2021
BioSpace
Paige and Leica Biosystems Partner to Expand Access to Computational Pathology Products for Pathology and Oncology Research - read this article along with other careers information, tips and advice on BioSpace
Reza Chowdhury
February 1, 2021
AlleyWatch
The Pulse of New York Tech
Conor Hale
January 14, 2021
FierceBiotech
After scoring two European approvals last month for its artificial-intelligence-powered cancer pathology platforms, Paige has secured $100 million in new funding to boost its development of biomarkers as clinical applications.
Christine Persaud
December 16, 2020
Digital Trends
Not every show on Apple's new streaming service is worth the price of admission. There are, however, some quality offerings if you know where to look.
Conor Hale
December 11, 2020
FierceBiotech
Digital pathology developer Paige has received two European approvals for its artificial-intelligence-powered diagnostic platforms in breast and prostate cancers.
Conor Hale
November 20, 2020
FierceBiotech
Breast cancer diagnostic developer Agendia announced plans to integrate its genomic tests with Paige's artificial-intelligence-powered pathology services with the goal of building a new digital precision oncology platform.
Conor Hale
July 13, 2020
FierceBiotech
Memorial Sloan Kettering Cancer Center's digital cancer pathology spinout, Paige, has secured an additional $15 million from Goldman Sachs, bringing the company's total series B haul up to $70 million.
Ingrid Lunden
July 13, 2020
TechCrunch
Paige, the startup that spun out of the Memorial Sloan Kettering Cancer Center and launched in 2018 to help advance cancer research and care by applying AI to better understand cancer pathology, is today announcing a milestone in its growth story: it has raised a further $20 million from Goldman Sachs and Healthcare Venture Partners, [...]
Ingrid Lunden
April 23, 2020
TechCrunch
Paige, the Sloan-Kettering spinout that has been building an artificial intelligence platform to improve cancer pathology and subsequently use those insights to develop better drug therapies, has raised an additional $5 million in funding to continue its work commercialising its platform and expanding its research reach, while also getting FDA clearance to launch in hospitals [...]
Ingrid Lunden
December 18, 2019
TechCrunch
One of the more notable startups using artificial intelligence to understand and fight cancer has raised $45 million more in funding to continue building out its operations and inch closer to commercialising its work. Paige -- which applies AI-based methods such as machine learning to better map the pathology of cancer, an essential component of [...]
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.